Measurement of basophil-activating capacity of grass pollen allergens, allergoids and hypoallergenic recombinant derivatives by flow cytometry using anti-CD203c

Clinical and Experimental Allergy

Volumn 33, Issue 9, 2003, Pages 1266-1272

  Kahlert, Helga ^a   Cromwell, O ^a   Fiebig, H ^a  

^a ALLERGOPHARMA JOACHIM GANZER KG   (Germany)

Author keywords

Allergen derivative; Allergoid; Basophil activation; CD203c; Hypoallergenic allergen variants; Phl p 1; Phl p 5; Recombinant allergen

Indexed keywords

ALLERGEN; ANTIBODY; CD203C ANTIBODY; HISTAMINE; POLLEN ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASOPHIL; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DELETION MUTANT; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; GRASS POLLEN; HISTAMINE RELEASE; HUMAN; MALE; MEASUREMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ALLERGENS; ANTIBODIES, MONOCLONAL; BASOPHILS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; HISTAMINE RELEASE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; PHOSPHORIC DIESTER HYDROLASES; PLANT EXTRACTS; POACEAE; POLLEN; PYROPHOSPHATASES; RECOMBINATION, GENETIC;

EID: 0043237876     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2003.01756.x     Document Type: Article

References (28)

1. Norman PS, Lawrence MD, Lichtenstein M, Kagey-Sobotka A, Marsh DG. Controlled evaluation of allergoid in immunotherapy of ragweed hay fever. J Allergy Clin Immunol 1982; 70:248-60.
2. Marsh DG, Lichtenstein LMN, Campbell DH. Studies on 'allergoids' prepared from naturally occurring allergens. I. Assay of allergenicity and antigenicity of formalized rye group I component. Immunology 1971; 18:705-22.
3. Marsh DG. Preparation and properties of 'allergoids' derived from native pollen allergens by mild formalin treatment. Int Arch Allergy Appl Immunol 1971; 41:199-215.
4. Puttonen E, Maasch HJ, Pilström L. Studies on allergen and allergoid preparations from purified Timothy (Phleum pratense) pollen extracts. I. Physicochemical characteristics and binding to allergen-specific human IgE. Int Arch Allergy Appl Immunol 1982; 68:1-6.
5. Wihl JA, Pilström L, Maasch H. Studies on allergen and allergoid preparations from purified Timothy (Phleum pratense) pollen extracts. III. Comparative investigations by skin prick test and nasal provocation tests. Int Arch Allergy Appl Immunol 1985; 76:162-7.
6. Kahlert H, Stüwe H-T, Cromwell O, Fiebig H. Reactivity of T cells with grass pollen allergen extract and allergoid. Int Arch Allergy Immunol 1999; 120:146-57.
7. Kahlert H, Grage-Griebenow E, Stüwe H-T, Cromwell O, Fiebig H. T cell reactivity of allergoids: Influence of the type of APC. J Immunol 2000; 165:1807-15.
8. Schramm G, Kahlert H, Suck R et al. 'Allergen engineering': variants of the timothy grass pollen allergen Phl p 5b with reduced IgE-binding capacity but conserved T-cell reactivity. J Immunol 1999; 162:2406-14.
9. Fiebig H, Suck R, Kahlert H, Weber B, Altmann F. Immunologische Eigenschaften von rekombinanten Allergenen. In: Ring J, Darsow U., eds. Allergic 2000: Probleme, Strategien und praktische Konsequenzen, 21. Tagung der DGAI 20.-24.10.1999, DustriVerlag Dr. Karl Feistle 1999:75-82.
10. Vrtala S, Hirtenlehner K, Vangelista L et al. Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments. J Clin Invest 1997; 99:1673-81.
11. Vrtala S, Hirtenlehner K, Susani M et al. Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v l: candidates for specific immunotherapy. Int Arch Allergy Immunol 1999; 118:218-9.
12. Swoboda I, De Weerd N, Bhalla PL et al. Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE-binding capacity: candidates for grass pollen-specific immunotherapy. Eur J Immunol 2002; 32:270-80.
13. Paris-Köhler A, Demoly P, Persi L, Lebel B, Bousquet J, Arnoux B. In vitro diagnosis of cypress pollen allergy by using cytofluorimetric analysis of basophils (Basotest). J Allergy Clin Immunol 2000; 105:339-45.
14. Sanz ML, Sánchez G, Gamboa PM et al. Allergen-induced basophil activation: CD63 cell expression detected by flow cytometry in patients allergic to Dermatophagoides pteronyssinus and Lolium perenne. Clin Exp Allergy 2001; 31:1007-13.
15. Saporta M, Kamei S, Persi L, Bousquet J, Arnoux B. Basophil activation during pollen season in patients monosensitized to grass pollens. Allergy 2001; 56:442-5.
16. Hauswirth AW, Natter S, Ghannadan M et al. Recombinant allergens promote expression of CD203c on basophils in sensitized individuals. J Allergy Clin Immunol 2002; 110:102-9.
17. Bühring H-J, Simmons PJ, Pudney M et al. The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors. Blood 1999; 94:2343-56.
18. Platz IJ, Binder M, Marxer A, Lischka G, Valent P, Bühring H-J. Hymenoptera-venom-induced upregulation of the basophil activation marker ecto-nucleotide pyrophosphatase/phosphodiesterase 3 in sensitized individuals. Int Arch Allergy Immunol 2001; 126:335-42.
19. Kahlert H, Weber B, Cromwell O, Fiebig H. Evaluation of the allergenicity of hypoallergenic recombinant derivatives of Bet v l using basophil activation by CD203c expression measurement. Clin Immunol Allergy Med Proceedings of the 21st EAACI Congress 2002, Naples, Italy:739-44.
20. Kahlert H, Weber B, Cromwell O, Fiebig H. Evaluation of the allergenicity of allergoids and hypoallergenic recombinant allergens using basophil activation by detection of CD203c. Allergy 2002; 57 (Suppl. 73):58 (abstract 144).
21. Weber B, Fiebig H, Cromwell O. Die Quantifizierung von Hauptallergenen als Teil der Qualitätsprüfung industriell hergestellter Allergenpräparate. Allergologie 1998; 21:116-24.
22. Suck R, Hagen S, Cromwell O, Fiebig H. Rapid and efficient purification of Phleum pratense major allergens Phi p 1 and group Phl p 2/3 using a two-step procedure. J Immunol Meth 1999; 229:73-80.
23. Haddad ZH, Marsh DG, Campbell DH. Studies on 'allergoids' prepared from naturally occurring allergens. II. Evaluation of allergenicity and assay of antigenicity of formalinized mixed grass pollen extracts. J Allergy Clin Immunol 1972; 49:197-209.
24. Petersen A, Becker W-M, Schlaak M. Characterization of isoforms of the major allergen Phi p V by two-dimensional immunoblotting and microsequencing. Int Arch Allergy Immunol 1992; 98:105-9.
25. Petersen A, Becker W-M, Schlaak M. Epitope analysis of isoforms of the major allergen Phl p V by fingerprinting and microsequencing. Clin Exp Allergy 1994; 24:250-6.
26. Petersen A, Schramm G, Bufe A, Schlaak M, Becker W-M. Structural investigations of the major allergen Phl p 1 on the complementary DNA and protein level. J Allergy Clin Immunol 1995; 95:987-94.
27. Smith PM, Ong EK, Know RB, Sing MB. Immunological relationships among group I and group V allergens from grass pollen. Mol Immunol 1994; 31:491-8.
28. Gelhar K, Petersen A, Schramm G, Becker W-M, Schlaak M, Bufe A. Investigation on different recombinant isoforms of grass group V allergens (timothy grass pollen) isolated by low stringency cDNA hybridization: antibody-binding capacity and allergenic activity. Eur J Biochem 1997; 247:217-23.